CRVS
Corvus Pharmaceuticals
$10.52
−$0.02 (−0.19%)Oct 28, 2026
Key metrics
The numbers that frame CRVS today
- Market cap
- $884.95M
- ROIC
- -40.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $6.39
- 52wk High
- $26.95
Growth
Revenue and earnings trend for CRVS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRVS
Is Corvus Pharmaceuticals a good buy?
No. Corvus Pharmaceuticals has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Corvus Pharmaceuticals is selling at a high price.
What is the market capitalization of CRVS?
Corvus Pharmaceuticals's market capitalization is $884.95M.
What is the 52-week high for CRVS stock?
The 52-week high for Corvus Pharmaceuticals is $26.95. The current close of $10.52 is 61% below that high.
What is the 52-week low for CRVS stock?
The 52-week low for Corvus Pharmaceuticals is $6.39. The current close of $10.52 is 64.6% above that low.
Does CRVS stock pay dividends?
Corvus Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRVS?
Corvus Pharmaceuticals's Debt / Equity ratio is 0.